Ipamorelin Testing

MW: 711.86 g/molHalf-life: ~2 hours

Selective pentapeptide GHRP. Minimal cortisol/prolactin release.

Mechanism of action

Selective ghrelin/GHSR agonist; pentapeptide. Stimulates pulsatile growth hormone release with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from older GHRPs (GHRP-2, GHRP-6, hexarelin).

Sequence & structure

H-Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Three non-natural amino acids (Aib, D-2-Nal, D-Phe). C-terminal amidation is essential.

Research areas

  • GH-deficiency research
  • Recovery and body composition
  • Combined GHRH + GHRP protocols (with CJC-1295)

Dosing in the literature

Research dosing 100–300 μg SC. Typically combined with a GHRH analog (CJC-1295) for synergistic GH release.

For research/informational purposes only — not medical advice.

What we test on Ipamorelin

Short peptide, easy to test cleanly. RP-HPLC, MS/MS sequence and stereo confirmation, endotoxin.

Standard GH Secretagogues Panel
  • RP-HPLC purity
  • ESI-MS identity
  • Amino acid analysis
  • Residual solvents (GC-MS)

Common impurities & failure modes

  • Racemized D-amino acid positions

    D-Phe or D-2-Nal converting to L-form destroys receptor selectivity. Chiral analysis or co-elution with reference standard required.

  • Free acid (failed amidation)

    −1 Da shift; significant potency loss.

  • Aib substitution failures

    Replacement with Ala or Gly happens in poor syntheses.

Related GH Secretagogues peptides